logo
logo

Cure Vac N.V. Appoints Thaminda Ramanayake As Chief Business Officer

Apr 29, 2024•over 1 year ago

Position

Chief Business Officer

Company

CureVac

Thaminda Ramanayake
TübingenBiotechnologyHealth Care

Description

CureVac N.V., a global biopharmaceutical company, has announced the appointment of Thaminda Ramanayake to the role of Chief Business Officer, effective June 1, 2024. Mr. Ramanayake brings over fifteen years of experience in biopharma company development and deal-making, with a strong track record of successful clinical collaborations, M&A, asset in-licensing, and strategic financing initiatives across multiple therapeutic areas.

Company Information

Company

CureVac

Location

Tübingen, Baden-Württemberg, Germany

About

CureVac is a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA) for the prevention and treatment of a range of infectious diseases, cancer and rare diseases. The company is pioneering the use of natural and chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months